Ribociclib for post-menopausal women with HR+/HER2- advanced or metastatic breast cancer. [electronic resource]
Producer: 20171108Description: 1169-1176 p. digitalISSN:- 1751-2441
- Aminopyridines -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Breast Neoplasms -- drug therapy
- Cyclin-Dependent Kinase 4 -- antagonists & inhibitors
- Cyclin-Dependent Kinase 6 -- antagonists & inhibitors
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Humans
- Neoplasm Metastasis
- Neutropenia -- chemically induced
- Postmenopause
- Purines -- administration & dosage
- Receptor, ErbB-2 -- metabolism
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.